Patents by Inventor Heinrich Maria SCHULTE

Heinrich Maria SCHULTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230251242
    Abstract: The disclosure concerns a method and a device for enriching cells, cell fragments and molecules from whole blood for a specific detection of at least one population of cells, cell fragments or molecules contained therein. The task was to detect a broad spectrum of target objects including their molecules simply, quickly and yet sensitively and specifically from whole blood. According to the disclosure, not the target objects themselves, but matrix objects are specifically enriched, but target objects are specifically analyzed and thus a specific and sensitive detection of target objects is achieved.
    Type: Application
    Filed: March 17, 2023
    Publication date: August 10, 2023
    Inventors: Rolf GÜNTHER, Tobias PÖHLMANN, Heinrich Maria SCHULTE
  • Patent number: 11629374
    Abstract: The disclosure concerns a method and a device for enriching cells, cell fragments and molecules from whole blood for a specific detection of at least one population of cells, cell fragments or molecules contained therein. The task was to detect a broad spectrum of target objects including their molecules simply, quickly and yet sensitively and specifically from whole blood. According to the disclosure, not the target objects themselves, but matrix objects are specifically enriched, but target objects are specifically analyzed and thus a specific and sensitive detection of target objects is achieved.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: April 18, 2023
    Inventors: Rolf Günther, Tobias Pöhlmann, Heinrich Maria Schulte
  • Publication number: 20210393668
    Abstract: In a method of treating a patient having a solid tumor, the solid tumor is completely or partially resected or ablated and then a therapeutically-effective amount of an oligonucleotide that kills tumor cells is applied or administered in a body cavity created by the resection or ablation in order to kill tumor cells remaining in, or in the surroundings of, a tumor bed and/or to suppress metastases. Thus, the oligonucleotide counteracts the development of recurrences of the solid tumor or new metastases. The oligonucleotide may act, e.g., in a pleiotropic manner in at least one type of tumor cell.
    Type: Application
    Filed: January 21, 2020
    Publication date: December 23, 2021
    Inventor: Heinrich Maria SCHULTE
  • Publication number: 20200032318
    Abstract: The disclosure concerns a method and a device for enriching cells, cell fragments and molecules from whole blood for a specific detection of at least one population of cells, cell fragments or molecules contained therein. The task was to detect a broad spectrum of target objects including their molecules simply, quickly and yet sensitively and specifically from whole blood. According to the disclosure, not the target objects themselves, but matrix objects are specifically enriched, but target objects are specifically analyzed and thus a specific and sensitive detection of target objects is achieved.
    Type: Application
    Filed: October 4, 2019
    Publication date: January 30, 2020
    Inventors: Rolf GÜNTHER, Tobias PÖHLMANN, Heinrich Maria SCHULTE